298 related articles for article (PubMed ID: 26640901)
21. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
[TBL] [Abstract][Full Text] [Related]
22. Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.
Campos-Varela I; Agudelo EZ; Sarkar M; Roberts JP; Terrault NA
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125670
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC
Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630
[TBL] [Abstract][Full Text] [Related]
24. Maximizing donors with viral hepatitis in the current era.
Brown K
Liver Transpl; 2017 Oct; 23(S1):S44-S49. PubMed ID: 28846183
[No Abstract] [Full Text] [Related]
25. Prognosis of Patients Following Liver Transplant From Deceased and Living Donors.
Yesmembetov K; Sultanaliyev T; Mukazhanov A; Zhexembayev A; Kuttymuratov G; Spatayev Z; Mussin Y; Umbetzhanov Y; Orazbayeva D
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):152-153. PubMed ID: 29528015
[TBL] [Abstract][Full Text] [Related]
26. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
Flemming JA; Kim WR; Brosgart CL; Terrault NA
Hepatology; 2017 Mar; 65(3):804-812. PubMed ID: 28012259
[TBL] [Abstract][Full Text] [Related]
27. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.
Lanini S; Nanni Costa A; Grossi PA; Procaccio F; Ricci A; Capobianchi MR; Terrault NA; Ippolito G
Liver Int; 2016 Mar; 36(3):410-7. PubMed ID: 26264452
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C genotype change after transplantation utilizing hepatitis C positive donor organs.
Adekunle R; Jonchhe S; Ravichandran B; Wilson E; Husson J
Transpl Infect Dis; 2018 Aug; 20(4):e12925. PubMed ID: 29797655
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.
Gitto S; Belli LS; Vukotic R; Lorenzini S; Airoldi A; Cicero AF; Vangeli M; Brodosi L; Panno AM; Di Donato R; Cescon M; Grazi GL; De Carlis L; Pinna AD; Bernardi M; Andreone P
World J Gastroenterol; 2015 Apr; 21(13):3912-20. PubMed ID: 25852276
[TBL] [Abstract][Full Text] [Related]
30. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.
Hu Z; Zhou J; Li Z; Xiang J; Zhang Q; Yan S; Wu J; Zhang M; Wang W; Zheng S
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):206-216. PubMed ID: 28107613
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era.
Latt NL; Alachkar N; Taydas E; Cameron A; Gurakar A
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():45-9. PubMed ID: 24635792
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
Price JC; Terrault NA
Liver Transpl; 2015 Apr; 21(4):423-34. PubMed ID: 25604355
[TBL] [Abstract][Full Text] [Related]
33. Recurrent hepatitis C after liver transplant.
deLemos AS; Schmeltzer PA; Russo MW
World J Gastroenterol; 2014 Aug; 20(31):10668-81. PubMed ID: 25152571
[TBL] [Abstract][Full Text] [Related]
34. A Follow-Up Study on the Renal Protective Efficacy of Telbivudine for Hepatitis B Virus-Infected Taiwanese Patients After Living Donor Liver Transplant.
Lin KH; Chen YL; Lin PY; Hsieh CE; Ko CJ; Lin CC; Ming YZ
Exp Clin Transplant; 2017 Feb; 15(1):65-68. PubMed ID: 28004999
[TBL] [Abstract][Full Text] [Related]
35. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
[TBL] [Abstract][Full Text] [Related]
36. The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study.
Denewar AA; Monem El-Hendy YA; Wafa EW; Ghorab AA; Sheashaa HA; Rashad RH; Nagib AM; Neamatallah AH; Abbas MH; Shokeir AA
Exp Clin Transplant; 2015 Oct; 13(5):402-7. PubMed ID: 26450463
[TBL] [Abstract][Full Text] [Related]
37. Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection.
Weiler N; Zeuzem S; Welker MW
World J Gastroenterol; 2016 Nov; 22(41):9044-9056. PubMed ID: 27895394
[TBL] [Abstract][Full Text] [Related]
38. Use of Elderly Allografts in Liver Transplantation.
Paterno F; Wima K; Hoehn RS; Cuffy MC; Diwan TS; Woodle SE; Abbott DE; Shah SA
Transplantation; 2016 Jan; 100(1):153-8. PubMed ID: 26154390
[TBL] [Abstract][Full Text] [Related]
39. Current management and perspectives for HCV recurrence after liver transplantation.
Coilly A; Roche B; Samuel D
Liver Int; 2013 Feb; 33 Suppl 1():56-62. PubMed ID: 23286847
[TBL] [Abstract][Full Text] [Related]
40. Adult Liver Allocation in Eurotransplant.
Jochmans I; van Rosmalen M; Pirenne J; Samuel U
Transplantation; 2017 Jul; 101(7):1542-1550. PubMed ID: 28060242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
